Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
St. Kitts and Nevis enters New Space through historic life sciences mission with Switzerland
EIN Presswire
Caribbean–Swiss partnership launches space biology experiment to advance STEM education, research capacity, and international collaboration.
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
GlobeNewswire, Inc.
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...
Introducing Obyte Friends: Rewards for Connections and Active Staking
EIN Presswire
Obyte community members can now make 1% a day by making friends every day and spreading the word about Obyte's unstoppable, censorship-resistant tech TRIESEN, LIECHTENSTEIN, January 2, 2026 /EINPresswire.com/ -- Obyte, the DAG-based...
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
GlobeNewswire, Inc.
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients.
CEO Insight’s Investors Guide Examines Evolving Investment Strategies Across Global Financial Markets
EIN Presswire
Featuring senior industry voices, the issue explores cross-border investment, financial innovation and the growing importance of trust in global markets.
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
GlobeNewswire, Inc.
First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...
Alex Lawton Becomes CEO of Clear Street U.K. Following FCA Approval
GlobeNewswire, Inc.
LONDON, May 06, 2026 (GLOBE NEWSWIRE) -- Clear Street ("Clear Street" or "the Company"), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access to every asset in every market, through a unified...
Clear Street Expands European Market Access with MiFID II License in the Netherlands
GlobeNewswire, Inc.
License Marks the Latest Step in Clear Street's Global Expansion Plan Strengthens Growing European Presence Alongside its Established U.K. Operations NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Clear Street ("Clear Street" or "the Company"), a...
IronWallet Tackles Cryptocurrency Barriers with Gasless Transactions and Privacy-First Approach
GlobeNewswire, Inc.
SCHAAN, Liechtenstein, Dec. 30, 2025 (GLOBE NEWSWIRE) -- IronWallet, a new cryptocurrency platform, aims to address several longstanding challenges that have hindered broader adoption of digital currencies.
Apax Digital Funds invest $60 million in MillTech to fuel North American expansion
GlobeNewswire, Inc.
• Investment to accelerate expansion in North America and enhance product offering • Values MillTech at $325m • MillTech reports c.$500bn annual trading volume, $35bn in client programmes and 70%+ revenue growth LONDON, April 09, 2026 (GLOBE...
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
GlobeNewswire, Inc.
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...
ThinkCareBelieve: Week 43 of America's Climb into the Golden Age
GlobeNewswire, Inc.
Link to Week 43 Article: https://thinkcarebelieve.blog/2025/11/15/week-43-the-reopening-of-america/ WASHINGTON, Nov. 15, 2025 (GLOBE NEWSWIRE) -- ThinkCareBelieve has published an article on Week 43 on the Reopening of America under the leadership...
Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
xMoney secures $21.5m strategic funding led by Sui Foundation
GlobeNewswire, Inc.
VADUZ, Liechtenstein, Sept. 30, 2025 (GLOBE NEWSWIRE) -- xMoney, the payments company bridging stablecoins and global commerce, announced today that it has raised $21.5 million in strategic funding with the Sui Foundation leading the round.
OilXCoin Launches Secondary Market Trading and Acquires O&G Lease in Kansas, USA
GlobeNewswire, Inc.
OilXCoin Launches Secondary Market Trading and Acquires O&G Lease in Kansas, USA Trading commences on Archax and Assetera, marking a major milestone in bringing the world’s most traded commodity on-chain.
xMoney introduces XMN as new token powering its ecosystem and the future of payments
GlobeNewswire, Inc.
VADUZ, Liechtenstein, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The financial payments industry just got a major upgrade. xMoney, the pioneering payments company, is entering a new era with the launch of its XMN token, bolstering the company’s token...
The European Magazine Releases Its Winter 2026 Edition
EIN Presswire
The Winter 2026 edition of The European is out now. Order your print or digital copy for exclusive interviews, expert analysis and global insights.
OG of fast cars drops in games: Porsche adopts in-car gaming with AirConsole
GlobeNewswire, Inc.
Zurich, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AirConsole, the pioneering in-car gaming platform that transforms car rides into shared entertainment experiences, is arriving in the new Porsche Macan later this year.
Regulating Artificial Intelligence in a Fragmented World — RegulatingAI Podcast
EIN Presswire
AI is reshaping democracy faster than rules can follow.
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
GlobeNewswire, Inc.
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS Pharma’s partner, ALK-Abelló A/S, who owns the rights to market EURneffy in the EU, will distribute following expected...
Sign up for:
Arts View Liechtenstein
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.